BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 30201376)

  • 1. Selective peroxisome proliferator-activated receptor-α modulator K-877 regulates the expression of ATP-binding cassette transporter A1 in pancreatic beta cells.
    Dong T; Lyu J; Imachi H; Kobayashi T; Fukunaga K; Sato S; Ibata T; Yoshimoto T; Yonezaki K; Iwama H; Zhang G; Murao K
    Eur J Pharmacol; 2018 Nov; 838():78-84. PubMed ID: 30201376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases.
    Yamashita S; Masuda D; Matsuzawa Y
    Curr Atheroscler Rep; 2020 Jan; 22(1):5. PubMed ID: 31974794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia.
    Fruchart JC
    Cardiovasc Diabetol; 2017 Oct; 16(1):124. PubMed ID: 28978316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
    Fruchart JC; Santos RD; Aguilar-Salinas C; Aikawa M; Al Rasadi K; Amarenco P; Barter PJ; Ceska R; Corsini A; Després JP; Duriez P; Eckel RH; Ezhov MV; Farnier M; Ginsberg HN; Hermans MP; Ishibashi S; Karpe F; Kodama T; Koenig W; Krempf M; Lim S; Lorenzatti AJ; McPherson R; Nuñez-Cortes JM; Nordestgaard BG; Ogawa H; Packard CJ; Plutzky J; Ponte-Negretti CI; Pradhan A; Ray KK; Reiner Ž; Ridker PM; Ruscica M; Sadikot S; Shimano H; Sritara P; Stock JK; Su TC; Susekov AV; Tartar A; Taskinen MR; Tenenbaum A; Tokgözoğlu LS; Tomlinson B; Tybjærg-Hansen A; Valensi P; Vrablík M; Wahli W; Watts GF; Yamashita S; Yokote K; Zambon A; Libby P
    Cardiovasc Diabetol; 2019 Jun; 18(1):71. PubMed ID: 31164165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fucoidan A3 from the seaweed Ascophyllum nodosum enhances RCT-related genes expression in hyperlipidemic C57BL/6J mice.
    Yang Z; Yin J; Wang Y; Wang J; Xia B; Li T; Yang X; Hu S; Ji C; Guo S
    Int J Biol Macromol; 2019 Aug; 134():759-769. PubMed ID: 31100394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of lipid profile by secretory phospholipase A2 group IIA: Verification with a transgenic mouse model.
    Liang L; Song J; Miao S; Xie Q; Li W; Huang H; Shen D; Zhang W
    Biochem Biophys Res Commun; 2024 Jun; 712-713():149955. PubMed ID: 38640737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR Agonists and Metabolic Syndrome: An Established Role?
    Botta M; Audano M; Sahebkar A; Sirtori CR; Mitro N; Ruscica M
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29662003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion.
    Kitamura S; Murao N; Yokota S; Shimizu M; Ono T; Seino Y; Suzuki A; Maejima Y; Shimomura K
    BMC Res Notes; 2023 Sep; 16(1):202. PubMed ID: 37697384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ishophloroglucin A, A Component of
    Yang HW; Son M; Choi J; Oh S; Jeon YJ; Byun K; Ryu B
    Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31731426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel ABCA1 peptide agonists with antidiabetic action.
    Azhar S; Bittner S; Hu J; Shen WJ; Cortez Y; Hao X; Han L; Lagerstedt JO; Kraemer FB; Johansson JO
    Mol Cell Endocrinol; 2019 Jan; 480():1-11. PubMed ID: 30290217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pan-PPAR agonist E17241 ameliorates hyperglycemia and diabetic dyslipidemia in KKAy mice via up-regulating ABCA1 in islet, liver, and white adipose tissue.
    Sheng R; Li Y; Wu Y; Liu C; Wang W; Han X; Li Y; Lei L; Jiang X; Zhang Y; Zhang Y; Li S; Hong B; Liu C; Xu Y; Si S
    Biomed Pharmacother; 2024 Mar; 172():116220. PubMed ID: 38308968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrate protects against high-fat diet-induced atherosclerosis via up-regulating ABCA1 expression in apolipoprotein E-deficiency mice.
    Du Y; Li X; Su C; Xi M; Zhang X; Jiang Z; Wang L; Hong B
    Br J Pharmacol; 2020 Apr; 177(8):1754-1772. PubMed ID: 31769014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pemafibrate on lipid profile and insulin resistance in hypertriglyceridemic patients with coronary artery disease and metabolic syndrome.
    Nakamura A; Kagaya Y; Saito H; Kanazawa M; Sato K; Miura M; Kondo M; Endo H
    Heart Vessels; 2024 Jun; 39(6):486-495. PubMed ID: 38393377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-144-3p Inhibits Host Lipid Catabolism and Autophagy by Targeting PPARα and ABCA1 During
    Wu J; Zhang Y; Tang H; Ye BC
    ACS Infect Dis; 2024 May; 10(5):1654-1663. PubMed ID: 38578697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol homeostasis regulated by ABCA1 is critical for retinal ganglion cell survival.
    Yang J; Chen Y; Zou T; Xue B; Yang F; Wang X; Huo Y; Yan B; Xu Y; He S; Yin Y; Wang J; Zhu X; Zhang L; Zhou Y; Tai Z; Shuai P; Yu M; Luo Q; Cheng Y; Gong B; Zhu X; Zhang J; Sun X; Lin Y; Zhang H; Yang Z
    Sci China Life Sci; 2023 Feb; 66(2):211-225. PubMed ID: 35829808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of UBE2E2 in Mouse Pancreatic β-Cells Leads to Glucose Intolerance via Reduction of β-Cell Mass.
    Sakurai Y; Kubota N; Takamoto I; Wada N; Aihara M; Hayashi T; Kubota T; Hiraike Y; Sasako T; Nakao H; Aiba A; Chikaoka Y; Kawamura T; Kadowaki T; Yamauchi T
    Diabetes; 2024 Mar; 73(3):474-489. PubMed ID: 38064504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of Molecular Mechanism of a Selective PPARα Modulator, Pemafibrate, through Combinational Approaches of X-ray Crystallography, Thermodynamic Analysis, and First-Principle Calculations.
    Kawasaki M; Kambe A; Yamamoto Y; Arulmozhiraja S; Ito S; Nakagawa Y; Tokiwa H; Nakano S; Shimano H
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosolic pH is a direct nexus in linking environmental cues with insulin processing and secretion in pancreatic β cells.
    Fang Y; Feng H; Zhang B; Zhang S; Zhou Y; Hao P; Zhou Z; Zhou S; Li N; Hui Y; Ma L; Xiong J; Wu J; Liu L; Zhang X
    Cell Metab; 2024 Jun; 36(6):1237-1251.e4. PubMed ID: 38513648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective roles of adiponectin and molecular signatures of HNF4α and PPARα as downstream targets of adiponectin in pancreatic β cells.
    Onodera T; Kim DS; Ye R; Wang MY; Chen S; Field BC; Straub L; Sun XN; Li C; Lee C; Paredes M; Crewe C; Zhao S; Kusminski CM; Gordillo R; Scherer PE
    Mol Metab; 2023 Dec; 78():101821. PubMed ID: 37806486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Pemafibrate on Reducing Oxidative Stress and Augmenting Angiogenesis in Ischemic Limb Tissue.
    Anegawa T; Sasaki KI; Ishizaki Y; Negoto S; Oryoji A; Nakamura E; Otsuka H; Hiromatsu S; Fukumoto Y; Tayama E
    Kurume Med J; 2024 May; 69(3.4):167-174. PubMed ID: 38233183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.